Bodal Chemicals FY26 Net Profit Rises 158% to Rs 478M

Board approved audited standalone and consolidated financial results for FY ended March 31, 2026, showing significant profit growth.
Approved sale of inoperative Unit I at Vatva, Ahmedabad, as part of non-core asset monetization strategy.
Revenue includes Rs 269.80M SGST incentive income recognition from Punjab Industrial Scheme for multiple periods.
Auditors provided unmodified opinion but emphasized SGST incentive recognition based on management assessment.